News

October 3rd, 2025

Psilmi™ Beta is Here – Join the Future of Objective Psychiatry

September 12th, 2025

PR: Stardots launches beta version of its Psilmi™ platform for autism and ADHD diagnosis and establishes new clinical partnerships

July 28th, 2025

Stardots aims to optimize deep brain stimulation treatment for Parkinson’s patients in new clinical study

June 11th, 2025

PM – Stardots submits patent application for its PSI platform following clinical results on autism and ADHD

February 17th, 2025

Stardots finalist in the Entrepreneurs Future Forecast of the Year.

February 6th, 2025

PM – Stardots includes first subject in clinical trial of ANLIVA® in the U.S.

February 6th, 2025

ANLIVA Eye Movement as a potential digital biomarker

February 5th, 2025

Stardots Shines in Industrifonden’s Latest Deep Tech Funding Report

February 5th, 2025

Stardots to initiate clinical study of ANLIVA DBS in Parkinson’s disease patients in collaboration with Dartmouth Hitchcock Medical Center

January 29th, 2025

ANLIVA Hand Movement – standardizing care for patients with motor symptoms

Next page

Stay up-to-date

Sign up to receive updates on our latest developments.